Howard Hughes Medical Institute Boosted Stake in Credit Accep Corp Mich (CACC)

November 14, 2017 - By Adrian Mccoy

Investors sentiment decreased to 1.3 in Q2 2017. Its down 0.01, from 1.31 in 2017Q1. It worsened, as 20 investors sold CACC shares while 43 reduced holdings. 29 funds opened positions while 53 raised stakes. 13.72 million shares or 4.67% more from 13.11 million shares in 2017Q1 were reported. Schwab Charles Invest Inc owns 0.02% invested in Credit Acceptance Corp. (NASDAQ:CACC) for 67,285 shares. Grantham Mayo Van Otterloo Commerce Ltd Liability Com holds 203,000 shares or 0.29% of its portfolio. Bluecrest Cap Ltd invested in 0.01% or 1,252 shares. Wellington Mgmt Group Llp holds 460,418 shares or 0.03% of its portfolio. Metropolitan Life Insur New York owns 754 shares. Ubs Asset Mgmt Americas Inc owns 0% invested in Credit Acceptance Corp. (NASDAQ:CACC) for 5,092 shares. Ftb Inc holds 0% in Credit Acceptance Corp. (NASDAQ:CACC) or 96 shares. Ingalls Snyder Ltd invested 1.27% in Credit Acceptance Corp. (NASDAQ:CACC). Franklin reported 0% in Credit Acceptance Corp. (NASDAQ:CACC). The Connecticut-based Aqr has invested 0.01% in Credit Acceptance Corp. (NASDAQ:CACC). Sg Americas Ltd Company reported 0% in Credit Acceptance Corp. (NASDAQ:CACC). Force Capital Ltd Liability reported 5,236 shares. Ameriprise reported 4,143 shares. Millennium Management Limited Liability Company accumulated 0.08% or 178,617 shares. Fmr Ltd Liability Co holds 7,275 shares or 0% of its portfolio.

Since May 15, 2017, it had 0 buys, and 16 selling transactions for $56.34 million activity.

Howard Hughes Medical Institute increased its stake in Credit Accep Corp Mich (CACC) by 55.24% based on its latest 2017Q2 regulatory filing with the SEC. Howard Hughes Medical Institute bought 28,082 shares as the company’s stock rose 15.18% with the market. The institutional investor held 78,918 shares of the consumer services company at the end of 2017Q2, valued at $20.29M, up from 50,836 at the end of the previous reported quarter. Howard Hughes Medical Institute who had been investing in Credit Accep Corp Mich for a number of months, seems to be bullish on the $5.50 billion market cap company. The stock declined 0.30% or $0.85 reaching $284.21 on the news. About 109,314 shares traded. Credit Acceptance Corp. (NASDAQ:CACC) has risen 27.46% since November 14, 2016 and is uptrending. It has outperformed by 10.76% the S&P500.

More notable recent Credit Acceptance Corp. (NASDAQ:CACC) news were published by: which released: “Credit Acceptance Corporation’s (CACC) CEO Brett Roberts on Q3 2017 Results …” on October 31, 2017, also with their article: “Credit Acceptance Corp. (CACC) PT Raised to $275 at Jefferies Following 3Q” published on October 31, 2017, published: “Credit Acceptance Named to the Detroit Free Press 2017 Top Workplaces List” on November 06, 2017. More interesting news about Credit Acceptance Corp. (NASDAQ:CACC) were released by: and their article: “Credit Acceptance Corp.: Finding A Niche And Owning It” published on July 13, 2017 as well as‘s news article titled: “Credit Acceptance Corporation – One Of The Best” with publication date: September 07, 2017.

Credit Acceptance Corp. (NASDAQ:CACC) Ratings Coverage

Among 11 analysts covering Credit Acceptance Corp (NASDAQ:CACC), 0 have Buy rating, 6 Sell and 5 Hold. Therefore 0 are positive. Credit Acceptance Corp has $275.0 highest and $150 lowest target. $219.67’s average target is -22.71% below currents $284.21 stock price. Credit Acceptance Corp had 23 analyst reports since July 31, 2015 according to SRatingsIntel. The stock of Credit Acceptance Corp. (NASDAQ:CACC) has “Hold” rating given on Thursday, September 7 by Jefferies. The stock of Credit Acceptance Corp. (NASDAQ:CACC) has “Underperform” rating given on Wednesday, May 11 by Macquarie Research. The firm earned “Hold” rating on Tuesday, October 31 by Jefferies. The stock of Credit Acceptance Corp. (NASDAQ:CACC) has “Buy” rating given on Tuesday, August 4 by Zacks. Credit Suisse maintained the shares of CACC in report on Tuesday, August 1 with “Sell” rating. On Tuesday, November 10 the stock rating was upgraded by Compass Point to “Neutral”. The rating was maintained by BMO Capital Markets on Tuesday, August 1 with “Market Perform”. BMO Capital Markets maintained it with “Market Perform” rating and $252 target in Tuesday, October 31 report. Compass Point downgraded the shares of CACC in report on Tuesday, September 6 to “Sell” rating. Credit Suisse downgraded the shares of CACC in report on Wednesday, July 27 to “Underperform” rating.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.